Comparing Fulgent Genetics (NASDAQ:FLGT) & Agilon Health (NYSE:AGL)

Fulgent Genetics (NASDAQ:FLGT) and Agilon Health (NYSE:AGL) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership and analyst recommendations.

Profitability

This table compares Fulgent Genetics and Agilon Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Fulgent Genetics	-26.05%	-4.93%	-4.50%
Agilon Health	-3.92%	-119.38%	-16.85%

Analyst Recommendations

This is a summary of recent ratings and price targets for Fulgent Genetics and Agilon Health, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fulgent Genetics	1	2	1	0	2.00
Agilon Health	2	6	6	0	2.29

Fulgent Genetics currently has a consensus target price of $27.50, suggesting a potential upside of 36.61%. Agilon Health has a consensus target price of $102.25, suggesting a potential upside of 12.61%. Given Fulgent Genetics’ higher probable upside, equities research analysts plainly believe Fulgent Genetics is more favorable than Agilon Health.

Earnings & Valuation

This table compares Fulgent Genetics and Agilon Health”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fulgent Genetics	$322.67 million	1.72	-$60.51 million	($2.82)	-7.14
Agilon Health	$5.93 billion	0.26	-$391.35 million	($14.27)	-6.36

Fulgent Genetics has higher earnings, but lower revenue than Agilon Health. Fulgent Genetics is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Fulgent Genetics has a beta of 0.93, suggesting that its share price is 7% less volatile than the S&P 500. Comparatively, Agilon Health has a beta of 2.98, suggesting that its share price is 198% more volatile than the S&P 500.

Institutional and Insider Ownership

48.1% of Fulgent Genetics shares are owned by institutional investors. 36.2% of Fulgent Genetics shares are owned by company insiders. Comparatively, 2.5% of Agilon Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Fulgent Genetics beats Agilon Health on 8 of the 13 factors compared between the two stocks.

About Fulgent Genetics

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company’s clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.

About Agilon Health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.